Pfizer (Pharmaceuticals) Overview
- Year Founded
-
1848

- Status
-
Public
- Employees
-
88,000

- Stock Symbol
-
PFE

- Investments
-
149
- Share Price
-
$25.74
- (As of Friday Closing)
Pfizer (Pharmaceuticals) General Information
Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
Contact Information
Website
www.pfizer.comCorporate Office
- 66 Hudson Boulevard East
- New York, NY 10001-2192
- United States
Corporate Office
- 66 Hudson Boulevard East
- New York, NY 10001-2192
- United States
Pfizer (Pharmaceuticals) Timeline
Pfizer (Pharmaceuticals) Stock Performance
As of 07-Feb-2025, Pfizer (Pharmaceuticals)’s stock price is $25.74. Its current market cap is $146B with 5.67B shares.
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$25.74 | $25.83 | $24.48 - $31.54 | $146B | 5.67B | 43.5M | $1.42 |
Pfizer (Pharmaceuticals) Financials Summary
As of 31-Dec-2024, Pfizer (Pharmaceuticals) has a trailing 12-month revenue of $63.6B.
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 207,282,246 | 207,282,246 | 182,245,239 | 287,439,237 |
Revenue | 63,627,000 | 63,627,000 | 58,496,000 | 100,330,000 |
EBITDA | 15,855,000 | 15,855,000 | 7,933,000 | 40,780,000 |
Net Income | 8,031,000 | 8,031,000 | 2,119,000 | 31,372,000 |
Total Assets | 226,501,000 | 197,205,000 | ||
Total Debt | 0 | 0 | 70,845,000 | 34,859,000 |
Pfizer (Pharmaceuticals) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Pfizer (Pharmaceuticals) Comparisons
Industry
Financing
Details
Pfizer (Pharmaceuticals) Competitors (27)
One of Pfizer (Pharmaceuticals)’s 27 competitors is Merck & Co., a Corporation company based in Rahway, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Merck & Co. | Corporation | Rahway, NJ | ||||
GSK | Corporation | Middlesex, United Kingdom | ||||
Johnson & Johnson | Corporation | New Brunswick, NJ | ||||
AbbVie | Corporation | North Chicago, IL | ||||
AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom |
Pfizer (Pharmaceuticals) Patents
Pfizer (Pharmaceuticals) Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2024151316-A | Rna molecule | Pending | 11-Apr-2023 | ||
JP-2024075506-A | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Pending | 22-Nov-2022 | ||
JP-2024047569-A | 3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-dione as mek inhibitor | Pending | 26-Sep-2022 | ||
JP-2024041730-A | Modulator for sting (stimulator of interferon genes) | Pending | 14-Sep-2022 | ||
JP-2024000530-A | Escherichia coli fimh mutants and uses thereof | Pending | 20-Jun-2022 |
Pfizer (Pharmaceuticals) Signals
Pfizer (Pharmaceuticals) Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Pfizer (Pharmaceuticals) Investments & Acquisitions (149)
Pfizer (Pharmaceuticals)’s most recent deal was a Later Stage VC with F2G for . The deal was made on 12-Sep-2024.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
F2G | 12-Sep-2024 | Later Stage VC | Drug Discovery | ||
Vedanta Biosciences | 05-Aug-2024 | Later Stage VC | Drug Discovery | ||
CytoReason | 15-Jul-2024 | Later Stage VC | Discovery Tools (Healthcare) | ||
Seagen | 14-Dec-2023 | Merger/Acquisition | Drug Discovery | ||
Theragraph | 03-Aug-2023 | Accelerator/Incubator | Other Healthcare Technology Systems |
Pfizer (Pharmaceuticals) ESG
Risk Overview
Risk Rating
Updated January, 22, 2025
19.36 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,120
Rank
Percentile

Pharmaceuticals
Industry
of 853
Rank
Percentile

Pharmaceuticals
Subindustry
of 425
Rank
Percentile

Pfizer (Pharmaceuticals) Exits (45)
Pfizer (Pharmaceuticals)’s most recent exit was on 30-Jun-2023 from Caribou Biosciences. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Caribou Biosciences | 30-Jun-2023 | Completed |
|
||
Telavant | 01-Dec-2022 | Completed |
|
||
Akero Therapeutics | 17-Jun-2022 | Completed |
|
||
GeneDx Holding | 02-May-2022 | Completed |
|
||
MAI Therapeutics | 20-Aug-2021 | Early Stage VC | Completed |
|
Affiliates
Subsidiaries (20)
Name | Industry | Location | Year Founded |
---|---|---|---|
Pfizer Saudi | Riyadh, Saudi Arabia | 2017 | |
Biohaven | Tortola, VI | 2013 | |
Lucira Health | Emeryville, CA | 2012 | |
Hospira 401(K) Retirement Savings Plan | Peapack, NJ | 2004 | |
Pfizer Ventures | New York, NY | 2004 |
Pfizer (Pharmaceuticals) FAQs
-
When was Pfizer (Pharmaceuticals) founded?
Pfizer (Pharmaceuticals) was founded in 1848.
-
Where is Pfizer (Pharmaceuticals) headquartered?
Pfizer (Pharmaceuticals) is headquartered in New York, NY.
-
What is the size of Pfizer (Pharmaceuticals)?
Pfizer (Pharmaceuticals) has 88,000 total employees.
-
What industry is Pfizer (Pharmaceuticals) in?
Pfizer (Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is Pfizer (Pharmaceuticals) a private or public company?
Pfizer (Pharmaceuticals) is a Public company.
-
What is Pfizer (Pharmaceuticals)’s stock symbol?
The ticker symbol for Pfizer (Pharmaceuticals) is PFE.
-
What is the current stock price of Pfizer (Pharmaceuticals)?
As of 07-Feb-2025 the stock price of Pfizer (Pharmaceuticals) is $25.74.
-
What is the current market cap of Pfizer (Pharmaceuticals)?
The current market capitalization of Pfizer (Pharmaceuticals) is $146B.
-
What is Pfizer (Pharmaceuticals)’s current revenue?
The trailing twelve month revenue for Pfizer (Pharmaceuticals) is $63.6B.
-
Who are Pfizer (Pharmaceuticals)’s competitors?
Merck & Co., GSK, Johnson & Johnson, AbbVie, and AstraZeneca are some of the 27 competitors of Pfizer (Pharmaceuticals).
-
What is Pfizer (Pharmaceuticals)’s annual earnings per share (EPS)?
Pfizer (Pharmaceuticals)’s EPS for 12 months was $1.42.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »